A prospective cohort study (Haller et al. 2021) investigated the use, benefits, and safety of craniosacral therapy (CST).
Outpatients who received CST from 2015 to 2019 were asked to provide anonymized data on symptom intensity, functional disability, and quality of life before and after treatment. Treatment expectations, therapies, medications, and safety were also assessed.
CST therapists submitted 220 patient records (71.4% female), including 15.5% infants and toddlers, 7.7% children, and 76.8% adolescents and adults. Patients received an average of about 7 CST sessions for the treatment of 114 different acute and chronic conditions. Symptom intensity decreased significantly by -4.38 NRS (95% CI = -4.69/-4.07), disability by -4.41 NRS (95% CI = -4.78/-4.05), and quality of life improved by 2.94 NRS (95% CI = 2.62/3.27). Furthermore, CST improved personal resources by 3.10 NRS (95% CI = 1.99/4.21).
Independent positive predictors of change in the adjusted Measure Yourself Medical Outcome Profile total score were patient expectations (p = .001) and therapist CST experience (p = .013); negative predictors were symptom duration (p < <.002) and patient age (p = .021); a final categorical predictor was CST type (p = .023). The best results were observed with structural approaches in combination with somato-emotional CST techniques, while biodynamic techniques alone or together with structural techniques led to slightly lower results. Minor but no serious adverse events occurred.
Conclusions: In primary care, patients and parents of minor children use CST for preventive and therapeutic purposes. Taking into account design limitations, CST appears to be effective and safe overall in infants, children, and adults.
Methodology: Consecutive outpatients who received CST treatment from 2015 to 2019 were asked to
Consecutive outpatients in the treatment period from 2015–2019 were asked to provide anonymized data on symptom intensity, functional impairment, and quality of life before and after treatment, which were collected using an adapted 11-point numerical rating scale (NRS) of the “Measure Yourself Medical Outcome Profile” (MYMOP).
Mean differences were analyzed using t-tests with 95% confidence intervals (CI), and predictors of treatment response were analyzed using linear regression modeling.
Haller H, Dobos G, Cramer H. The use and benefits of Craniosacral Therapy in primary health care: A prospective cohort study. Complement Ther Med. 2021 May;58:102702. doi: 10.1016/j.ctim.2021.102702.
https://pubmed.ncbi.nlm.nih.gov/33647398/
Craniosacral therapy appears to be effective and safe overall in infants, children, and adults.
A prospective cohort study (Haller et al. 2021) investigated the use, benefits, and safety of craniosacral therapy (CST).
Outpatients receiving CST from 2015 to 2019 were asked to provide anonymized data on symptom intensity, functional disability, and quality of life before and after treatment. Treatment expectations, therapies, medications, and safety were also assessed.
CST therapists submitted 220 patient records (71.4% female), including 15.5% infants and toddlers, 7.7% children, and 76.8% adolescents and adults. Patients received an average of about 7 CST sessions for the treatment of 114 different acute and chronic conditions. Symptom intensity significantly decreased by -4.38 NRS (95% CI = -4.69/-4.07), disability by -4.41 NRS (95% CI = -4.78/-4.05), and quality of life improved by 2.94 NRS (95% CI = 2.62/3.27). In addition, CST improved personal resources by 3.10 NRS (95% CI = 1.99/4.21).
Independent positive predictors of change in the adjusted Measure Yourself Medical Outcome Profile total score were patient expectations (p = .001) and therapist CST experience (p = .013); negative predictors were symptom duration (p < <.002) and patient age (p = .021); a final categorical predictor was CST type (p = .023). The best results were observed with structural approaches in combination with somato-emotional CST techniques, while biodynamic techniques alone or together with structural techniques led to slightly lower results. Minor but no serious adverse events occurred.
Conclusions: In primary care, patients and parents of minor children use CST for preventive and therapeutic purposes. Taking into account design limitations, CST appears to be effective and safe overall in infants, children, and adults.
Methods: Consecutive outpatients who received CST treatment from 2015 to 2019 were asked,
Anonymized data on symptom intensity of consecutive outpatients in the treatment period from 2015–2019 were asked to report functional impairment and quality of life before and after treatment, collected using an adapted 11-item Measure Yourself Medical Outcome Profile (MYMOP) numerical rating scale (NRS).
Mean differences were analyzed using t-tests with 95% confidence intervals (CI), and predictors of treatment response were analyzed using linear regression modeling.
Haller H, Dobos G, Cramer H. The use and benefits of Craniosacral Therapy in primary health care: A prospective cohort study. Complement Ther Med. 2021 May;58:102702. doi: 10.1016/j.ctim.2021.102702. https://pubmed.ncbi.nlm.nih.gov/33647398/
